63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model

P.Wachsberger; R.Burd; T.Strickler; K.Kulp; A.Ryan; A.Dicker

首页> 外文期刊>European Journal of Cancer Supplements >63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model

【24h】

63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model

机译：63 POSTER在LoVo人大肠癌异种移植模型中将ZD644（ZACTIMA）与再用疗法和伊立替康组合使用可提高抗肿瘤活性

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第12期|共1页
作者
P.Wachsberger; R.Burd; T.Strickler; K.Kulp; A.Ryan; A.Dicker;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model [J] . P.Wachsberger, R.Burd, T.Strickler, European Journal of Cancer Supplements . 2006,第12期

机译：63 POSTER在LoVo人大肠癌异种移植模型中将ZD644（ZACTIMA）与再用疗法和伊立替康组合使用可提高抗肿瘤活性
2. Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models [J] . Jianping Chen, Melissa Smith, Kenneth Kolinsky, Cancer Chemotherapy and Pharmacology . 2007,第5期

机译：HER1 / EGFR酪氨酸激酶抑制剂埃洛替尼单独或与CPT-11（伊立替康）联合在人大肠癌异种移植模型中的抗肿瘤活性
3. Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model. [J] . Wachsberger P, Burd R, Ryan A International Journal of Radiation Oncology, Biology, Physics . 2009,第3期

机译：LoVo人结肠直肠癌异种移植模型中vandetanib，放疗和伊立替康的组合。
4. Non-invasive and real-time monitoring of molecular targeting therapy for lymph node and peritoneal metastasis in nude mice bearing xenografts of human colorectal cancer cells tagged with GFP and DsRed [C] . Hayao Nakanishi, Masayasu Hara, Yuzuru Ikehara, Genetically Engineered and Optical Probes for Biomedical Applications IV; Progress in Biomedical Optics and Imaging; vol.8 no.26; Proceedings of SPIE-The International Society for Optical Engineering; vol.6449 . 2007

机译：非侵入性实时监测分子靶向疗法对带有GFP和DsRed标签的人大肠癌细胞异种移植的裸鼠淋巴结和腹膜转移的作用
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model [O] . SUGURU HARADA, MIEKO YANAGISAWA, SAORI KANEKO, -1

机译：曲妥珠单抗联合卡培他滨加奥沙利铂在人表皮生长因子受体2阳性人胃癌异种移植模型中的优异抗肿瘤活性
7. Combination of Vandetanib, Radiotherapy, and Irinotecan in the LoVo Human Colorectal Cancer Xenograft Model [O] . Wachsberger PhD Phyllis, Burd PhD Randy, Ryan PhD Anderson, 2016

机译：LoVo人结直肠癌异种移植模型中Vandetanib，放射疗法和伊立替康的组合

63 POSTER Improved antitumor activity by combining ZD644 (ZACTIMA) with rediotherapy and irinotecan in the LoVo human colorectal cancer xenograft model

著录项

相似文献

相关主题

期刊订阅